Last reviewed · How we verify
Haemophilus Septicemia
Approved treatments
- Cefadole
Cefadole works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. - Ceftriaxon · Centre Hospitalier Universitaire Vaudois
- Fortaz · Pai Holdings Pharm
Fortaz works by binding to penicillin-binding proteins on bacterial cell walls, preventing them from forming a strong cell wall and ultimately leading to bacterial cell death. - Zinacef · GSK
Zinacef works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. - Fortaz · Pai Holdings Pharm
Bactericidal agent inhibiting bacterial cell wall synthesis with beta-lactamase resistance. - Rocephin · Generic (originally Roche)
- Ceftazidim · Tel-Aviv Sourasky Medical Center
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Haemophilus Septicemia patent landscape — cliff calendar, originator estates, attackable patents
- Haemophilus Septicemia treatment landscape brief
- Haemophilus Septicemia treatment updates RSS
Frequently asked questions about Haemophilus Septicemia
What drugs treat Haemophilus Septicemia?
Tracked treatments include Cefadole, Ceftriaxon, Fortaz, Zinacef, Rocephin, Ceftazidim.
What is the treatment for Haemophilus Septicemia?
Standard treatment for Haemophilus Septicemia includes Cefadole, Ceftriaxon, Fortaz, Zinacef, Rocephin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Haemophilus Septicemia patent cliff · Haemophilus Septicemia CI report
- Treatment: Cefadole
- Treatment: Ceftriaxon · Centre Hospitalier Universitaire Vaudois
- Treatment: Fortaz · Pai Holdings Pharm
- Treatment: Zinacef · GSK
- Treatment: Fortaz · Pai Holdings Pharm
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing